🔎 Trials Near Me

Beranda › Diabetes Tipe 1 › Florida

Uji klinis Diabetes Tipe 1 di Florida

30 studi untuk Diabetes Tipe 1 mencari peserta di lokasi di Florida.

Kota di Florida

Teks studi resmi (Bahasa Inggris)

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

  • Clinical Pharmacology of Miami, Miami
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07803744

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  • Tallahassee Memorial HealthCare, Tallahassee
Menerima pesertaFase 3
Usia 1 hingga 35 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07222137

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  • Tallahassee Memorial HealthCare, Tallahassee
Menerima pesertaFase 3
Usia 1 hingga 35 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07222332

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • University of Florida College of Medicine- Site Number : 8400054, Gainesville
  • Encore Medical Research - Hollywood- Site Number : 8400061, Hollywood
  • Nemours Children's Speciality Care- Jacksonville- Site Number : 8400040, Jacksonville
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • Southwest General Healthcare Center, Fort Myers
  • University of Florida, Gainesville
  • Evolution Research Center, Hialeah
  • dan 4 lainnya
Menerima pesertaFase 1/2
Usia 12 hingga 35 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

  • University of Florida, Gainesville
Menerima pesertaFase 2
Usia 4 hingga 34 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  • University of Florida, Gainesville
  • University of Miami, Miami
  • USF Diabetes Center, Tampa
Menerima pesertaFase 2
Usia 8 hingga 45 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  • University of Florida, Gainesville
  • University of Miami, Miami
Menerima pesertaFase 1/2
Usia 9 hingga 20 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07061574

Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families

  • Nemours Children's Health, Jacksonville
Menerima peserta
Usia 8 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05268250

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  • UHealth Diabetes Research Institute, Miami
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04786262

HLA Demographics Study in Adults With Type 1 Diabetes

  • University of Florida- Gainesville, Gainesville
Menerima pesertaStudi observasional
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06860516

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

  • University of Florida College of Medicine, Gainesville
  • University of Miami - Gables One Tower, Miami
Menerima pesertaFase 2
Usia 5 hingga 40 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07187531

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

  • University of Florida, Gainsville
Menerima pesertaFase 2
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07224321

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

  • AdventHealth Translational Research Institute, Orlando
Menerima pesertaFase 2
Usia 18 hingga 40 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05478707

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

  • University of Florida - Gainesville, Gainesville
  • University of Miami, Diabetes Research Institute, Miami
Menerima pesertaFase 1
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06919354

Adapting Single Sessions Interventions for Type 1 Diabetes

  • Nemours Children's Hospital - FL, Orlando
Menerima peserta
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06752369

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

  • Nemours Children's Health, Jacksonville
  • Nemours Children's Health, Orlando
Menerima pesertaStudi observasional
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT05849753

Transdisciplinary Care for Young Adults With Type 1 Diabetes

  • Nemours Children's Health, Florida, Orlando
Menerima peserta
Usia 17 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06172166

Registry for Stage 2 Type 1 Diabetes

  • University of Florida Health- Site Number : 8400035, Gainesville
  • Nemours Children's Speciality Care- Jacksonville- Site Number : 8400006, Jacksonville
  • University of Miami Miller School of Medicine- Site Number : 8400037, Miami
  • dan 2 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06481904

Immune Function and the Progression to T1D

  • Kieran McGrail, Gainesville
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 100 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT05899439

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • AdventHealth, Orlando
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06217302

Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss

  • Diabetes Research Institute, Miami
Menerima pesertaStudi observasional
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT02000687

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • Diabetes Research Institute, Miami
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT01999361

Long Term Follow up of Recipients of Functional Islet Allografts

  • Diabetes Research Institute, Miami
Menerima pesertaStudi observasional
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT01999374

Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye

  • Bascom Palmer Eye Institute, Miami
  • Diabetes Research Institute, University of Miami Miller School of Medicine, Miami
Menerima pesertaFase 1/2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT02846571

Closed Loop and Education for Hypoglycemia Awareness Restoration

  • AdventHealth, Orlando
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Mar 2026 · NCT06325202

Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

  • Diabetes Research Institute, University of Miami Miller School of Medicine, Miami
Menerima pesertaFase 1/2
Usia 18 hingga 35 · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT05626712

Twiist Postmarket Surveillance Study for Type 1 Diabetes

  • Jaeb Center for Health Research, Tampa
Menerima pesertaStudi observasional
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT07356089

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

  • University of Florida, Gainesville
Menerima pesertaFase 2
Usia 6 hingga 35 · Semua jenis kelamin · Diperbarui 26 Nov 2025 · NCT06455319

TrialNet Pathway to Prevention of T1D

  • University of Florida, Gainesville
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 45 · Semua jenis kelamin · Diperbarui 1 Jul 2025 · NCT00097292

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.